MC-Val-Cit-PAB
                产品编号: DC10120
                
                         Featured
                        
            
            
         
        
        
            
            
            
                我们的合作伙伴:
                
                
                    中国地区超过5000个高品质化合物库存
                
             
         
        应用领域
        MC-Val-Cit-PAB是可被组织蛋白酶切割的ADC连接桥,用于制备抗体-药物偶联物。 美国FDA批准的药物,如brentuximab vedotin使用了该连接桥。
        
        
        
        
            
            
                
                    
                         
                        
                            | Cas No.: | 159857-80-4 | 
                         
                        
                            | 名称: |  | 
                        
                        
                            | 别名: |  | 
                        
                        
                            | SMILES: | CC(C)[C@@H](C(=O)N[C@@H](CCCNC(=O)N)C(=O)NC1=CC=C(C=C1)CO)NC(=O)CCCCCN2C(=O)C=CC2=O | 
                         
                       
                        | 分子式: | C28H40N6O7 | 
                         
                      
                        | 分子量: | 572.66 | 
                         
                        
                        | 纯度: |  | 
                         
                        
                        | 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO | 
                        
                      
                 
                
                    
                         
                            | Description: |  | 
                          
                        
                            | In Vivo: |  | 
                        
                        
                            | In Vitro: |  | 
                         
                        
                            | References: | MC-Val-Cit-PAB, also known as MC-Val-Cit-PAB-OH, is a cathepsin cleavable ADC peptide linker. MC-Val-Cit-PAB is useful for making ADC conjugate (antibody-drug conjugate). FDA approved drugs such as brentuximab vedotin used this linker. | 
                     
                      
                 
                
                    
                        
                          
                        
                            | Kinase Assay: |  | 
                        
                        
                            | Cell Assay: |  | 
                        
                        
                            | Animal Administration: |  | 
                        
                        
                            | References: |  | 
                        
                      
                 
                
                    MSDS
                    
                        
                             
                               
                                | TITLE | DOWNLOAD | 
                            
                            
                                | MSDS_103_DC10120_159857-80-4 |   | 
                            
                            
                            
                         
                    COA
                    
                        
                        
                            
                                | LOT NO. | DOWNLOAD | 
                            
                            
                                |  |   | 
                            
                        
                        
                     
                 
                
                
             
         
        询盘